NCT00034918View on ClinicalTrials.gov

This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

November 30, 2003

Conditions
Breast NeoplasmsMetastases, Neoplasm
Interventions
DRUG

ZD6474

Trial Locations (2)

Unknown

Research Site, Indianapolis

08035

Research Site, Barcelona

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00034918 - This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter